Search
Search Results
##search.searchResults.foundPlural##
-
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3990PDF: 1049HTML: 3589Untitled: 177Cneo. Fig.1: 113Untitled: 104Untitled: 126Untitled: 131 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2486PDF: 837HTML: 8819Efremov 1: 226Efremov 2: 187 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3287PDF: 1340HTML: 2625 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3051PDF: 873HTML: 7162Kost Fig1: 182Kost Fig 2: 177Kost Fig3: 174Kost Fig 4: 189Kost Fig5: 184Kost fig 6: 173 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3309PDF: 1465HTML: 3998 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2234PDF: 880HTML: 2000Fig 1 Rossi: 176 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1362PDF: 754HTML: 942 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2174PDF: 1197HTML: 3709 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2568PDF: 860HTML: 17469Fig1 Caligaris: 171Fig.2 Caliga: 203 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2850PDF: 1227HTML: 2698Figure 1: 171 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3539PDF: 1568HTML: 80 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1654PDF: 644HTML: 2431 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2285PDF: 1323HTML: 17076Bassan Fig.1: 143Bassan Fig.2: 153Bassan Fig.4: 142Fig.3: 184 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4109PDF: 3389HTML: 202 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4052PDF: 1923HTML: 5225Table 1: 190 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2317PDF: 982HTML: 7623Untitled: 273Fig2: 183Fig3: 168Fig4: 179 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3162PDF: 896HTML: 1533Fig.1 CHL-R paper: 214Fig 2 CHL-R paper: 237 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2212PDF: 1042HTML: 1981Characteristic of study group: 196 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1370HTML: 391PDF: 818 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2942PDF: 889HTML: 1870 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3748PDF: 1475HTML: 484Figures . Eliassian: 222 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3760PDF: 1652HTML: 11579Figures Haase: 198 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1331PDF: 822HTML: 129 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1482PDF: 764HTML: 202 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4088PDF: 1582HTML: 943







